Harding Loevner LP Abb Vie Inc. Transaction History

Harding Loevner LP

$12.6 Billion
Q1 2025

A detailed history of Harding Loevner LP transactions in Abb Vie Inc. stock. As of the latest transaction made, Harding Loevner LP holds 582,555 shares of ABBV stock, worth $115 Million. This represents 0.97% of its overall portfolio holdings.

Number of Shares

582,555

Previous 690,322 15.61%

Holding current value

$115 Million

Previous $123 Million 0.5%

% of portfolio

0.97%

Previous 0.85%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$169.2 - $216.66 $18.2 Million - $23.3 Million	-107,767 Reduced 15.61%	582,555 $122 Million
Q4 2024 Feb 14, 2025	SELL	$164.99 - $203.87 $23.2 Million - $28.7 Million	-140,658 Reduced 16.93%	690,322 $123 Million
Q3 2024 Nov 14, 2024	SELL	$163.84 - $199.33 $3.45 Million - $4.19 Million	-21,043 Reduced 2.47%	830,980 $164 Million
Q2 2024 Aug 14, 2024	SELL	$154.79 - $180.76 $4.06 Million - $4.74 Million	-26,217 Reduced 2.99%	852,023 $146 Million
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $12.2 Million - $13.9 Million	-76,397 Reduced 8.0%	878,240 $160 Million
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $1.89 Million - $2.13 Million	-13,719 Reduced 1.42%	954,637 $148 Million
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $16.1 Million - $18.6 Million	120,463 Added 14.21%	968,356 $144 Million
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $21.1 Million - $26.3 Million	-159,424 Reduced 15.83%	847,893 $114 Million
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $146 Million - $168 Million	1,007,317 New	1,007,317 $161 Million
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $27,715 - $34,387	-210 Reduced 24.79%	637 $96,000
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $52,684 - $57,999	515 Added 155.12%	847 $92,000
Q3 2020 Nov 16, 2020	BUY	$85.91 - $100.83 $15,463 - $18,149	180 Added 118.42%	332 $29,000
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $9,804 - $14,864	152 New	152 $12,000

Others Institutions Holding ABBV

# of Institutions

4,249

Shares Held

1.27B

Call Options Held

16.5M

Put Options Held

15M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $350B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harding Loevner LP, based on Form 13F filings with the SEC.

News

Stay updated on Harding Loevner LP with notifications on news.

Account

Harding Loevner LP Abb Vie Inc. Transaction History